Paradigm Biopharmaceuticals | PAR - Ordinary Share Capital

Stock Price
0.26
Daily Change
0 0%
Monthly
-11.86%
Yearly
-38.82%
Q1 Forecast
0.25

Paradigm Biopharmaceuticals reported AUD389.43M in Ordinary Share Capital for its fiscal semester ending in June of 2025.





Ordinary Share Capital Change Date
Medical Developments International AUD 112.66M 2.35M Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Pacific Edge NZD 1.02B 210.22M Dec/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025